跳至主要内容
临床试验/CTRI/2023/01/049280
CTRI/2023/01/049280尚未招募2 期

A Prospective Interventional randomized study to assess efficacy of Angiotensin Receptor Nephrilysin Inhibitor (Sacubitril/Valsartan) in right ventricular systolic dysfunction with normal LV functionâ??

MDM hospitalDr SN Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of Right Ventricular systolic dysfunction with Normal Left ventricular systolic function as diagnosed by transthoracic echocardiography parameters such as TAPSE( <16mm), PAsP( >25mm Hg), tricuspid annular velocity( <10 cm/sec), Fractional area change( <35%) and blood markers such as NT-proBNp( >400pg/ml).

排除标准

  • 1.Patients with LVEF <50%
  • 2.Pregnancy
  • 3. Severe hepatic impairment (Child. Pugh C)
  • 4.Severe renal imapairment (eGFR <30 ml/min/1.73m2)
  • Hypersensitivity to any component of the product
  • A prior history of angioedema due to an ACEI or ARB

研究者

发起方
MDM hospitalDr SN Medical College

相似试验